A just transition for antimicrobial resistance: planning for an equitable and sustainable future with antimicrobial resistance
Antimicrobial resistance (AMR) is among the most complex and urgent global health challenges of our time. Planning for a future with antimicrobial resistance, and reducing its burden in clinical, social, and economic terms, will require us to take notice of the unequal impact of AMR and the human rights of those populations most affected by drug resistance in present and future generations. Applying a 'just transition' framework to AMR allows us to put justice, equity, inclusivity and human rights at the heart of AMR decision-making and governance.
Read the full comment in The Lancet. This comment was written by the Just Transitions for AMR Working Group. Published online: September 08, 2023. DOI: https://doi.org/10.1016/S0140-6736(23)01687-2